View Older Stories View More Recent Stories

Nov 2, 2020 09:04AM Arcutis Biotherapeutics Inc. (ARQT) Highlights New Positive Data from Phase 2 Studies of ARQ-151 (Topical Roflumilast Cream)
Nov 2, 2020 09:00AM Arcutis Biotherapeutics Presents New Positive Data from Phase 2 Studies of ARQ-151 (Topical Roflumilast Cream) in Chronic Plaque Psoriasis and Atopic Dermatitis
Oct 29, 2020 09:07PM Arcutis Biotherapeutics to Present New Data from ARQ-151 (Topical Roflumilast Cream) Clinical Program at Three Global Dermatology Conferences
Oct 26, 2020 09:00AM Arcutis Completes Enrollment in Phase 1/2b Study Evaluating ARQ-252 in Chronic Hand Eczema
Sep 29, 2020 08:07AM Arcutis Biotherapeutics Inc. (ARQT) Reports Positive Topline Data from Phase 2 Clinical Trial Evaluating ARQ-154 (Topical Roflumilast Foam) as a Potential Treatment for Seborrheic Dermatitis
Sep 29, 2020 08:00AM Arcutis Announces Positive Topline Data from Phase 2 Clinical Trial Evaluating ARQ-154 (Topical Roflumilast Foam) as a Potential Treatment for Seborrheic Dermatitis
Sep 16, 2020 09:14AM Arcutis Biotherapeutics Inc. (ARQT) Reports Complete Enrollment in DERMIS-1 & DERMIS-2 Pivotal Phase 3 Clinical Trials Evaluating ARQ-151 as Potential Treatment for Plaque Psoriasis
Sep 16, 2020 09:00AM Arcutis Completes Enrollment in DERMIS-1 and DERMIS-2 Pivotal Phase 3 Clinical Trials Evaluating ARQ-151 (Topical Roflumilast Cream) as a Potential Treatment for Plaque Psoriasis
Sep 15, 2020 09:00AM Arcutis to Present at the Cantor Fitzgerald Global Healthcare Conference 2020
Sep 8, 2020 09:02AM Arcutis Biotherapeutics Inc. (ARQT) to Advance ARQ-151 (Topical Roflumilast Cream) into Phase 3 Trials Following End-of-Phase 2 Meeting with FDA
Sep 8, 2020 09:00AM Arcutis Biotherapeutics to Accelerate ARQ-151 (Topical Roflumilast Cream) into Phase 3 Trials for the Treatment of Atopic Dermatitis Following End-of-Phase 2 Meeting with FDA
Aug 11, 2020 04:02PM Arcutis Announces Second Quarter 2020 Financial Results and Provides Business Update
Aug 10, 2020 09:00AM Arcutis to Present at the Wedbush PacGrow Healthcare Conference
Aug 4, 2020 09:00AM Bethany Dudek Joins Arcutis as Vice President of Quality
Aug 3, 2020 09:04AM Arcutis Biotherapeutics Inc. (ARQT) Announces Publication of Data from Positive Phase 1/2a Trial of Arcutis’ ARQ-151 (Topical Roflumilast Cream)
Aug 3, 2020 09:00AM The Journal of Drugs in Dermatology Publishes Results from Positive Phase 1/2a Trial of Arcutis’ ARQ-151 (Topical Roflumilast Cream) for the Treatment of Chronic Plaque Psoriasis
Jul 31, 2020 09:01AM Arcutis Bio (ARQT) Says Preliminary Data from Long-Term Safety Study Support Chronic Use of ARQ-151 as Potential Treatment for Plaque Psoriasis
Jul 31, 2020 09:00AM Preliminary Data from Long-Term Safety Study Support Chronic Use of ARQ-151 (Topical Roflumilast Cream) as a Potential Treatment for Plaque Psoriasis
Jul 27, 2020 09:00AM Arcutis Appoints Patrick Burnett, M.D., Ph.D., FAAD, as Chief Medical Officer
Jul 20, 2020 09:07AM Arcutis Biotherapeutics Inc. (ARQT) Reports Last Patient Enrollment in Phase 2b Clinical Trial Evaluating ARQ-154 (Topical Roflumilast Foam) as Potential Treatment for Scalp Psoriasis
Jul 20, 2020 09:00AM Arcutis Enrolls Last Patient in Phase 2b Clinical Trial Evaluating ARQ-154 (Topical Roflumilast Foam) as a Potential Treatment for Scalp Psoriasis
Jul 15, 2020 05:08PM Arcutis Biotherapeutics Inc. (ARQT) Reports Publication of Results for Positive Phase 2b Trial of Arcutis’ ARQ-151 (Topical Roflumilast Cream) for Treatment of Chronic Plaque Psoriasis
Jul 15, 2020 05:07PM The New England Journal of Medicine Publishes Results from Positive Phase 2b Trial of Arcutis’ ARQ-151 (Topical Roflumilast Cream) for the Treatment of Chronic Plaque Psoriasis
Jul 15, 2020 05:06PM The New England Journal of Medicine Publishes Results from Positive Phase 2b Trial of Arcutis’ ARQ-151 (Topical Roflumilast Cream) for the Treatment of Chronic Plaque Psoriasis
Jul 13, 2020 09:00AM Arcutis Initiates Patient Enrollment in the Phase 2b Portion of the Phase 1/2b Study Evaluating ARQ-252 in Chronic Hand Eczema
View More Recent Stories View Older Stories